Clinical trial
Real-World Experience With the Use of PCSK9 Inhibitors in Patients With Hyperlipidemia and Atherosclerotic Cardiovascular Disease at a University Hospital in Bogotá, Colombia
NCT07856264 is registered in ClinicalTrials.gov with Fundación Santa Fe de Bogota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Experience With the Use of PCSK9 Inhibitors in Patients With Hyperlipidemia and Atherosclerotic Cardiovascular Disease at a University Hospital in Bogotá, Colombia
- Lead sponsor
- Fundación Santa Fe de Bogota
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2027
- Completion date
- July 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic cardiovascular disease (ascvd), hyperlipidemia